Pediatric Gynecologic Cancers.

Lauren Pommert, William Bradley
Author Information
  1. Lauren Pommert: Children's Hospital of Wisconsin, Department of Pediatrics, Hematology/Oncology/BMT, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
  2. William Bradley: Department of Obstetrics and Gynecology, Froedtert and the Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. wbradley@mcw.edu.

Abstract

PURPOSE OF REVIEW: Three primary categories of gynecologic cancer are found in pediatric and adolescent patients: stromal carcinomas including juvenile granulosa cell tumors and Sertoli-Leydig cell tumors, rhabdomyosarcomas arising from the vagina and cervix (sarcoma botryoides), and ovarian germ cell tumors which comprise a wide range of histologies. These entities are rare and treatment approaches have focused on decreasing late effects of chemotherapy treatment. Here, we review presentation, histologic classifications, diagnosis, and treatment recommendations for pediatric gynecologic cancers.
RECENT FINDINGS: Event-free and overall survival for these cancers is high, and the goals of treatment are minimization of morbidity and preservation of fertility with unilateral salpingo-oophorectomies and limited staging. Surveillance of tumor markers after surgery is helpful in monitoring for disease progression and adjuvant chemotherapy is often reserved for patients at recurrence. Recent literature supports avoiding chemotherapy even in high-grade germ cell tumors in the pediatric population.

Keywords

References

  1. Cancer. 2009 Sep 15;115(18):4218-26 [PMID: 19536876]
  2. J Pediatr Hematol Oncol. 2015 Nov;37(8):e486-9 [PMID: 26165406]
  3. Gynecol Oncol. 1997 Feb;64(2):282-4 [PMID: 9038278]
  4. MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92 [PMID: 26225476]
  5. Gynecol Oncol. 2016 Nov;143(2):428-432 [PMID: 27569583]
  6. Gynecol Oncol. 1997 Jun;65(3):447-52 [PMID: 9190974]
  7. J Pathol. 2014 Jul;233(3):209-14 [PMID: 24752781]
  8. Obstet Gynecol Sci. 2013 May;56(3):198-200 [PMID: 24328002]
  9. Int J Cancer. 2009 Apr 1;124(7):1626-36 [PMID: 19115209]
  10. Indian J Surg Oncol. 2013 Mar;4(1):37-47 [PMID: 24426698]
  11. J Clin Oncol. 1999 Nov;17(11):3487-93 [PMID: 10550146]
  12. J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):229-33 [PMID: 11990313]
  13. Obstet Gynecol Surv. 2014 Jan;69(1):29-38 [PMID: 25102249]
  14. Eur J Cancer. 2015 Mar;51(4):543-50 [PMID: 25514863]
  15. Cancer. 2001 Jun 15;91(12):2454-68 [PMID: 11413538]
  16. MMWR Morb Mortal Wkly Rep. 2016 Jul 08;65(26):661-6 [PMID: 27387669]
  17. Urol Oncol. 2016 Feb;34(2):103-15 [PMID: 26519985]
  18. J Clin Endocrinol Metab. 2006 May;91(5):1842-7 [PMID: 16507630]
  19. Cancer. 2010 Oct 15;116(20):4882-91 [PMID: 20597129]
  20. J Pediatr Adolesc Gynecol. 2009 Oct;22(5):e114-7 [PMID: 19576820]
  21. J Pediatr Surg. 1995 Jul;30(7):1034-6; discussion 1036-7 [PMID: 7472927]
  22. J Pediatr Hematol Oncol. 2014 May;36(4):263-70 [PMID: 24577549]
  23. J Pediatr Surg. 2014 Jul;49(7):1177-80 [PMID: 24952812]
  24. Cancer. 2016 Jan 15;122(2):230-7 [PMID: 26485622]
  25. Eur J Gynaecol Oncol. 2000;21(2):187-9 [PMID: 10843483]
  26. BMJ Open. 2015 Jan 08;5(1):e006030 [PMID: 25573522]
  27. Lancet Infect Dis. 2015 May;15(5):565-80 [PMID: 25744474]
  28. Gynecol Oncol. 1993 Jan;48(1):119-23 [PMID: 8423014]
  29. Curr Opin Oncol. 2008 May;20(3):315-20 [PMID: 18391632]
  30. Arch Gynecol Obstet. 2008 Jul;278(1):65-9 [PMID: 18427824]
  31. Pediatr Blood Cancer. 2015 Nov;62(11):1935-41 [PMID: 26150380]
  32. J Gen Intern Med. 2016 Nov;31(11):1360-1366 [PMID: 27184752]
  33. Clin Imaging. 2000 Sep-Oct;24(5):257-62 [PMID: 11331151]
  34. Gynecol Oncol. 2005 Dec;99(3):742-8 [PMID: 16214206]
  35. Eur J Cancer. 2000 Feb;36(3):376-83 [PMID: 10708940]
  36. J Clin Oncol. 2000 Nov 15;18(22):3809-18 [PMID: 11078494]
  37. J Clin Oncol. 2014 Feb 10;32(5):465-70 [PMID: 24395845]
  38. J Pediatr Hematol Oncol. 2012 May;34 Suppl 2:S55-63 [PMID: 22525408]
  39. JAMA Pediatr. 2014 Jan;168(1):76-82 [PMID: 24276343]
  40. Pediatr Blood Cancer. 2008 Jul;51(1):140-1 [PMID: 18253956]
  41. Virchows Arch. 2003 Oct;443(4):549-60 [PMID: 12910419]
  42. J Pediatr Surg. 1999 May;34(5):731-4; discussion 734-5 [PMID: 10359173]
  43. Clin Infect Dis. 2016 Nov 15;63(10 ):1281-1287 [PMID: 27655996]
  44. J Clin Oncol. 2015 Sep 20;33(27):3018-28 [PMID: 26304902]
  45. Pediatr Blood Cancer. 2011 Jul 1;56(7):1062-7 [PMID: 21488154]
  46. J Pediatr Hematol Oncol. 2013 May;35(4):e163-6 [PMID: 22735885]

MeSH Term

Adolescent
Biomarkers, Tumor
Child
Disease-Free Survival
Female
Genital Neoplasms, Female
Granulosa Cell Tumor
Humans
Rhabdomyosarcoma
Sarcoma
Sertoli-Leydig Cell Tumor
Vaginal Neoplasms

Chemicals

Biomarkers, Tumor

Word Cloud

Created with Highcharts 10.0.0celltumorstreatmentPediatricpediatricgermchemotherapygynecologicjuvenilegranulosaSertoli-LeydigovariancancerstumorPURPOSEOFREVIEW:Threeprimarycategoriescancerfoundadolescentpatients:stromalcarcinomasincludingrhabdomyosarcomasarisingvaginacervixsarcomabotryoidescomprisewiderangehistologiesentitiesrareapproachesfocuseddecreasinglateeffectsreviewpresentationhistologicclassificationsdiagnosisrecommendationsRECENTFINDINGS:Event-freeoverallsurvivalhighgoalsminimizationmorbiditypreservationfertilityunilateralsalpingo-oophorectomieslimitedstagingSurveillancemarkerssurgeryhelpfulmonitoringdiseaseprogressionadjuvantoftenreservedpatientsrecurrenceRecentliteraturesupportsavoidingevenhigh-gradepopulationGynecologicCancersGenitalrhabdomyosarcomaHumanpapillomavirusSmallcarcinoma

Similar Articles

Cited By